Other Guidelines | Page 57 | European Cystic Fibrosis Society (ECFS)

The fungal airway microbiome in cystic fibrosis and non-cystic fibrosis bronchiectasis

Clinimetric evaluation of muscle function tests for individuals with cystic fibrosis: A systematic review

A disruption of innervation around CF tissues results in low amount of VIP before CF disease has produced damage to the lungs and small intestine.

Immunotyping of clinically divergent p.Phe508del homozygous monozygous cystic fibrosis twins

CFTR modulator therapy for cystic fibrosis caused by the rare c.3700A>G mutation

Ebselen attenuates tobramycin-induced ototoxicity in mice

Pseudomonas aeruginosa antimicrobial susceptibility test (AST) results and pulmonary exacerbation treatment responses in cystic fibrosis

Lavage lipidomics signatures in children with cystic fibrosis and protracted bacterial bronchitis

“Mild” CFTR genetic variants might be associated with a lower than expected probability of developing CF

Amplifiers co-translationally enhance CFTR biosynthesis via PCBP1-mediated regulation of CFTR mRNA

first
previous
…
53
54
55
56
57
58
59
60
61
…
next
last